Factors influencing employees’ continuance intention in AI-powered digital learning: evidence from SMEs in Sichuan, China
The International Journal on e-Learning and Higher Education · 30.06.2026 · 21 (2) · 71-80
DOI: 10.24191/ijelhe.v21n2.2128 ↗Kurz gefasst
Fachartikel in der Zeitschrift The International Journal on e-Learning and Higher Education, online erschienen am 30.06.2026. Verfasst von Yao Wang und 1 weiteren Autor:innen.
Abstract (Originalsprache)
The research investigates which elements affect employee willingness to maintain their usage of AI-driven digital learning platforms within small and medium enterprises across Sichuan China. The study applies TAM and ECM to analyze how employees’ perceptions of system ease of use and usefulness affect their satisfaction levels and their decision to continue using the system. The research analyzed data from 312 employees across 87 SMEs through PLS-SEM. The research findings demonstrate that user satisfaction together with perceived usefulness directly affect continuance intention which helps organizations enhance their AI-based training programs for SMEs.
Zitieren
APA
Wang, Y., & Balakrishnan, R. (2026). Factors influencing employees’ continuance intention in AI-powered digital learning: evidence from SMEs in Sichuan, China. The International Journal on e-Learning and Higher Education, 21(2), 71-80. https://doi.org/10.24191/ijelhe.v21n2.2128
Vancouver
Wang Y, Balakrishnan R. Factors influencing employees’ continuance intention in AI-powered digital learning: evidence from SMEs in Sichuan, China. The International Journal on e-Learning and Higher Education. 2026;21(2):71-80. doi:10.24191/ijelhe.v21n2.2128
BibTeX
@article{Wang2026,
author = {Wang, Yao and Balakrishnan, Rajani},
title = {Factors influencing employees’ continuance intention in AI-powered digital learning: evidence from SMEs in Sichuan, China},
journal = {The International Journal on e-Learning and Higher Education},
year = {2026},
volume = {21},
number = {2},
pages = {71--80},
doi = {10.24191/ijelhe.v21n2.2128}
}
EUVIMED